R&D News | pharmaphorum

News

New Huntington’s drug granted priority designation

Roche’s treatment for Huntington’s disease has received a priority designation by the European regulator, sparking hope that a cure may be in the pipeline.

News

Neurofibromatosis treatment granted orphan status by EMA

AstraZeneca and Merck & Co.

News

New tuberculosis drug could help eradicate global killer

A groundbreaking drug, rifampin, could help to end the global tuberculosis epidemic, according to researchers.

Market Access

FDA grants leukaemia drug ‘breakthrough’ status

A leukaemia drug has been granted ‘breakthrough therapy’ status by the US drug regulator.

News

The first lipodystrophy treatment for European patients

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to impro

News

Shionogi's Mulpleta gets FDA green light for patients with l...

The US drug regulator has approved Mulpleta (lusutrombopag) as a treatment for thrombocytopenia in certain patients with chronic liver disease who are about to undergo a medical procedure.<

New Huntington’s drug granted priority designation

Neurofibromatosis treatment granted orphan status by EMA

New tuberculosis drug could help eradicate global killer

FDA grants leukaemia drug ‘breakthrough’ status

The first lipodystrophy treatment for European patients

Shionogi's Mulpleta gets FDA green light for patients with l...

Bavarian Nordic has found its new CEO

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks